PULMONX CORPORATION Operating Lease, Payments
PULMONX CORPORATION (LUNG) reported Operating Lease, Payments of $1.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-04
- PULMONX CORPORATION operating lease, payments for the quarter ending 2026-06-30 was $739.00K, a 12.23% decline year-over-year.
- PULMONX CORPORATION operating lease, payments for the quarter ending 2026-03-31 was $746.00K, a 56.72% increase year-over-year.
- PULMONX CORPORATION operating lease, payments for the quarter ending 2025-12-31 was $753.00K, a 102.42% increase year-over-year.
- PULMONX CORPORATION operating lease, payments for the quarter ending 2025-09-30 was $746.00K, a 20.64% decline year-over-year.
- PULMONX CORPORATION operating lease, payments for fiscal 2025 was $2.82M, a 10.09% decline from fiscal 2024.
- PULMONX CORPORATION operating lease, payments for fiscal 2024 was $3.13M, a 12.07% decline from fiscal 2023.
- PULMONX CORPORATION operating lease, payments for fiscal 2023 was $3.56M, a 31.91% increase from fiscal 2022.
- PULMONX CORPORATION operating lease, payments for fiscal 2022 was $2.70M, a 3.71% decline from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $739.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.49M 10-Q · filed 2026-08-04 | $2.24M derived: sum of 3 quarters · filed 2026-08-04 | $2.98M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $746.00K 10-Q · filed 2026-05-04 | $1.50M derived: sum of 2 quarters · filed 2026-05-04 | $2.25M derived: sum of 3 quarters · filed 2026-05-04 | $3.09M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $753.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.50M derived: sum of 2 quarters · filed 2026-03-10 | $2.34M derived: sum of 3 quarters · filed 2026-08-04 | $2.82M 10-K · filed 2026-03-10 |
| 2025-09-30 | $746.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.59M derived: sum of 2 quarters · filed 2026-08-04 | $2.06M 10-Q · filed 2025-11-12 | $2.44M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $842.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.32M 10-Q · filed 2026-08-04 | $1.69M derived: sum of 3 quarters · filed 2026-08-04 | $2.63M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $476.00K 10-Q · filed 2026-05-04 | $848.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.79M derived: sum of 3 quarters · filed 2026-05-04 | $2.70M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $372.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.31M derived: sum of 2 quarters · filed 2026-03-10 | $2.22M derived: sum of 3 quarters · filed 2026-03-10 | $3.13M 10-K · filed 2026-03-10 |
| 2024-09-30 | $940.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.85M derived: sum of 2 quarters · filed 2025-11-12 | $2.76M 10-Q · filed 2025-11-12 | $3.68M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $911.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $1.82M 10-Q · filed 2025-08-01 | $2.74M derived: sum of 3 quarters · filed 2025-08-01 | $3.64M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $910.00K 10-Q · filed 2025-05-02 | $1.83M derived: sum of 2 quarters · filed 2025-05-02 | $2.73M derived: sum of 3 quarters · filed 2025-05-02 | $3.60M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $918.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.81M derived: sum of 2 quarters · filed 2025-02-25 | $2.69M derived: sum of 3 quarters · filed 2025-02-25 | $3.56M 10-K · filed 2025-02-25 |
| 2023-09-30 | $897.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $1.77M derived: sum of 2 quarters · filed 2024-11-01 | $2.65M 10-Q · filed 2024-11-01 | $3.52M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $876.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $1.75M 10-Q · filed 2024-08-02 | $2.63M derived: sum of 3 quarters · filed 2024-08-02 | $3.48M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $872.00K 10-Q · filed 2024-05-03 | $1.75M derived: sum of 2 quarters · filed 2024-05-03 | $2.61M derived: sum of 3 quarters · filed 2024-05-03 | $3.44M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $879.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.74M derived: sum of 2 quarters · filed 2024-02-27 | $2.57M derived: sum of 3 quarters · filed 2024-02-27 | $2.70M 10-K · filed 2024-02-27 |
| 2022-09-30 | $856.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $1.69M derived: sum of 2 quarters · filed 2023-11-03 | $1.82M 10-Q · filed 2023-11-03 | $2.50M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $835.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $966.00K 10-Q · filed 2023-08-04 | $1.64M derived: sum of 3 quarters · filed 2023-08-04 | $2.44M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $131.00K 10-Q · filed 2023-05-08 | $809.00K derived: sum of 2 quarters · filed 2023-05-08 | $1.61M derived: sum of 3 quarters · filed 2023-05-08 | $2.40M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $678.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.48M derived: sum of 2 quarters · filed 2023-03-01 | $2.26M derived: sum of 3 quarters · filed 2023-03-01 | $2.81M 10-K · filed 2023-03-01 |
| 2021-09-30 | $797.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.59M derived: sum of 2 quarters · filed 2022-11-08 | $2.13M 10-Q · filed 2022-11-08 | $2.66M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $789.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.33M 10-Q · filed 2022-08-08 | $1.86M derived: sum of 3 quarters · filed 2022-08-08 | $2.33M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $541.00K 10-Q · filed 2022-05-09 | $1.07M derived: sum of 2 quarters · filed 2022-05-09 | $1.54M derived: sum of 3 quarters · filed 2022-05-09 | $1.81M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $531.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $996.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.27M derived: sum of 3 quarters · filed 2022-03-01 | $1.49M 10-K · filed 2022-03-01 |
| 2020-09-30 | $465.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $735.00K derived: sum of 2 quarters · filed 2021-11-09 | $963.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $498.00K 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $228.00K 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $893.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |